Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Angioedema Treatment
Revenue, means the sales value of Angioedema Treatment
This report studies Angioedema Treatment in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
AstraZeneca
F.Hoffmann-La Roche AG
Valeant Pharmaceuticals International
GlaxoSmithKline
AstraZeneca
Sanofi SA
Merck?Co
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Antihistamines
Corticosteroids
Others
Split by Application, this report focuses on consumption, market share and growth rate of Angioedema Treatment in each application, can be divided into
Hospitals
Clinics
Research Organizations?
China Angioedema Treatment Market Research Report 2017
1 Angioedema Treatment Market Overview
1.1 Product Overview and Scope of Angioedema Treatment
1.2 Angioedema Treatment Segment by Type
1.2.1 China Production Market Share of Angioedema Treatment Type in 2015
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Others
1.3 Applications of Angioedema Treatment
1.3.1 Angioedema Treatment Consumption Market Share by Application in 2015
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Organizations?
1.4 China Market Size (Value) of Angioedema Treatment (2012-2022)
1.5 China Angioedema Treatment Status and Outlook
1.6 Government Policies
2 China Angioedema Treatment Market Competition by Manufacturers
2.1 China Angioedema Treatment Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Angioedema Treatment Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Angioedema Treatment Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Angioedema Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Angioedema Treatment Market Competitive Situation and Trends
2.5.1 Angioedema Treatment Market Concentration Rate
2.5.2 Angioedema Treatment Market Share of Top 3 and Top 5 Manufacturers
3 China Angioedema Treatment Manufacturers Profiles/Analysis
3.1 AstraZeneca
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Angioedema Treatment Product Type, Application and Specification
3.1.2.1 Antihistamines
3.1.2.2 Corticosteroids
3.1.3 AstraZeneca Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 F.Hoffmann-La Roche AG
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Angioedema Treatment Product Type, Application and Specification
3.2.2.1 Antihistamines
3.2.2.2 Corticosteroids
3.2.3 F.Hoffmann-La Roche AG 121 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Valeant Pharmaceuticals International
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Angioedema Treatment Product Type, Application and Specification
3.3.2.1 Antihistamines
3.3.2.2 Corticosteroids
3.3.3 Valeant Pharmaceuticals International 131 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Angioedema Treatment Product Type, Application and Specification
3.4.2.1 Antihistamines
3.4.2.2 Corticosteroids
3.4.3 GlaxoSmithKline Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 AstraZeneca
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Angioedema Treatment Product Type, Application and Specification
3.5.2.1 Antihistamines
3.5.2.2 Corticosteroids
3.5.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Sanofi SA
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Angioedema Treatment Product Type, Application and Specification
3.6.2.1 Antihistamines
3.6.2.2 Corticosteroids
3.6.3 Sanofi SA Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Merck?Co
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Angioedema Treatment Product Type, Application and Specification
3.7.2.1 Antihistamines
3.7.2.2 Corticosteroids
3.7.3 Merck?Co Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
4 China Angioedema Treatment Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Angioedema Treatment Capacity, Production and Growth (2012-2017)
4.2 China Angioedema Treatment Revenue and Growth (2012-2017)
4.3 China Angioedema Treatment Production, Consumption, Export and Import (2012-2017)
5 China Angioedema Treatment Production, Revenue (Value), Price Trend by Type
5.1 China Angioedema Treatment Production and Market Share by Type (2012-2017)
5.2 China Angioedema Treatment Revenue and Market Share by Type (2012-2017)
5.3 China Angioedema Treatment Price by Type (2012-2017)
5.4 China Angioedema Treatment Production Growth by Type (2012-2017)
6 China Angioedema Treatment Market Analysis by Application
6.1 China Angioedema Treatment Consumption and Market Share by Application (2012-2017)
6.2 China Angioedema Treatment Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaAngioedema Treatment Market Analysis by Regions (Provinces)
7.1 China Angioedema Treatment Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Angioedema Treatment Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Angioedema Treatment Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Angioedema Treatment Sales Price by Regions (Provinces)(2012-2017)
7.2 China Angioedema Treatment Consumption by Regions (Provinces)(2012-2017)
7.3 China Angioedema Treatment Production, Consumption, Export and Import (2012-2017)
8 Angioedema Treatment Manufacturing Cost Analysis
8.1 Angioedema Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Angioedema Treatment
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Angioedema Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Angioedema Treatment Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Angioedema Treatment Market Forecast (2017-2022)
12.1 China Angioedema Treatment Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Angioedema Treatment Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Angioedema Treatment Production Forecast by Type (2017-2022)
12.4 China Angioedema Treatment Consumption Forecast by Application (2017-2022)
12.5 China Angioedema Treatment Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Angioedema Treatment Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Angioedema Treatment Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Angioedema Treatment Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Angioedema Treatment Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Angioedema Treatment
Figure China Production Market Share of Angioedema Treatment by Type in 2015
Figure Product Picture of Antihistamines
Table Major Manufacturers of Antihistamines
Figure Product Picture of Corticosteroids
Table Major Manufacturers of Corticosteroids
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Angioedema Treatment Consumption Market Share by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Research Organizations? Examples
Figure China Angioedema Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Table China Angioedema Treatment Capacity of Key Manufacturers (2015 and 2016)
Table China Angioedema Treatment Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Angioedema Treatment Capacity of Key Manufacturers in 2015
Figure China Angioedema Treatment Capacity of Key Manufacturers in 2016
Table China Angioedema Treatment Production of Key Manufacturers (2015 and 2016)
Table China Angioedema Treatment Production Share by Manufacturers (2015 and 2016)
Figure 2015 Angioedema Treatment Production Share by Manufacturers
Figure 2016 Angioedema Treatment Production Share by Manufacturers
Table China Angioedema Treatment Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Angioedema Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Angioedema Treatment Revenue Share by Manufacturers
Table 2016 China Angioedema Treatment Revenue Share by Manufacturers
Table China Market Angioedema Treatment Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Angioedema Treatment Average Price of Key Manufacturers in 2015
Table Manufacturers Angioedema Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Angioedema Treatment Product Type
Figure Angioedema Treatment Market Share of Top 3 Manufacturers
Figure Angioedema Treatment Market Share of Top 5 Manufacturers
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Angioedema Treatment Market Share (2012-2017)
Table F.Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F.Hoffmann-La Roche AG Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure F.Hoffmann-La Roche AG Angioedema Treatment Market Share (2012-2017)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International Angioedema Treatment Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Angioedema Treatment Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Angioedema Treatment Market Share (2012-2017)
Table Sanofi SA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi SA Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi SA Angioedema Treatment Market Share (2012-2017)
Table Merck?Co Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck?Co Angioedema Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck?Co Angioedema Treatment Market Share (2012-2017)
Figure China Angioedema Treatment Capacity, Production and Growth (2012-2017)
Figure China Angioedema Treatment Revenue (Million USD) and Growth (2012-2017)
Table China Angioedema Treatment Production, Consumption, Export and Import (2012-2017)
Table China Angioedema Treatment Production by Type (2012-2017)
Table China Angioedema Treatment Production Share by Type (2012-2017)
Figure Production Market Share of Angioedema Treatment by Type (2012-2017)
Figure 2015 Production Market Share of Angioedema Treatment by Type
Table China Angioedema Treatment Revenue by Type (2012-2017)
Table China Angioedema Treatment Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Angioedema Treatment by Type (2012-2017)
Figure 2015 Revenue Market Share of Angioedema Treatment by Type
Table China Angioedema Treatment Price by Type (2012-2017)
Figure China Angioedema Treatment Production Growth by Type (2012-2017)
Table China Angioedema Treatment Consumption by Application (2012-2017)
Table China Angioedema Treatment Consumption Market Share by Application (2012-2017)
Figure China Angioedema Treatment Consumption Market Share by Application in 2015
Table China Angioedema Treatment Consumption Growth Rate by Application (2012-2017)
Figure China Angioedema Treatment Consumption Growth Rate by Application (2012-2017)
Table China Angioedema Treatment Production by Regions (Provinces)(2012-2017)
Table China Angioedema Treatment Production Market Share by Regions (Provinces)(2012-2017)
Table China Angioedema Treatment Production Value by Regions (Provinces)(2012-2017)
Table China Angioedema Treatment Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Angioedema Treatment Sales Price by Regions (Provinces)(2012-2017)
Table China Angioedema Treatment Consumption by Regions (Provinces)(2012-2017)
Table China Angioedema Treatment Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Angioedema Treatment Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Angioedema Treatment
Figure Manufacturing Process Analysis of Angioedema Treatment
Figure Angioedema Treatment Industrial Chain Analysis
Table Raw Materials Sources of Angioedema Treatment Major Manufacturers in 2015
Table Major Buyers of Angioedema Treatment
Table Distributors/Traders List
Figure China Angioedema Treatment Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Angioedema Treatment Revenue and Growth Rate Forecast (2017-2022)
Table China Angioedema Treatment Production, Import, Export and Consumption Forecast (2017-2022)
Table China Angioedema Treatment Production Forecast by Type (2017-2022)
Table China Angioedema Treatment Consumption Forecast by Application (2017-2022)
Table China Angioedema Treatment Production Forecast by Regions (Provinces)(2017-2022)
Table China Angioedema Treatment Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Angioedema Treatment Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...